Loading…
Loading…
AIML.CN does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for AIML.CN and 80,000+ other tickers.
See exactly how AIML.CN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for AIML.CN and 80,000+ other tickers.
Operating within the digital healthcare sector, AI/ML Innovations Inc. harnesses the power of artificial intelligence (AI) and machine learning (ML). The company's central offering is a patent-pending system for personal health monitoring and management, crafted to enable caregivers, patients, and medical professionals to readily access and utilize data. This functionality aims to enhance patient recovery outcomes and promote overall healthy living. Complementing this, AI/ML Innovations Inc. also develops digital health software and wearable technologies. The organization, incorporated in…
GREENVILLE, South Carolina, June 09, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the "Company" or "ARCpoint") announces that its Board of Directors has appointed Peter Kendall as Interim Chief Executive Officer of the Company, effective June 9, 2026. Mr. Kendall's appointment remains subject to acceptance by the TSX Venture Exchange (the "TSXV" or the "Exchange"), including acceptance of the Exchange's required Personal Information Form and completion of customary Exchange review and verification procedures.
This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and digital health integration. Partnership positions MaxYield™ as a core AI engine for next-generation smart rings and consumer cardiac monitoring into the broader INTRINSICA platform.
Early collaboration supports development of Cornerstone's emerging athlete-performance program and extends NeuralCloud's ECG analytics into sports-science and human performance markets Pilot ties MaxYield™ signal enhancement with Insight360™ performance analytics for Hyrox athlete testing TORONTO, ON / ACCESS Newswire / December 2, 2025 / NeuralCloud Solutions Inc. ("NeuralCloud"), a subsidiary of AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), is pleased to announce that it has entered into a pilot collaboration with Cornerstone Physiotherapy ("Cornerstone"), a Canadian physiotherapy group, to evaluate NeuralCloud's MaxYield™ signal-processing engine and Insight360™ performance analytics within Cornerstone's developing elite athlete program. Cornerstone, co-founded by physiotherapist Adam Brown, is currently conducting a limited pilot with competitive Hyrox athletes as part of a broader initiative to build an evidence-based, physiotherapist-led performance program.